Introduction
eavy Menstrual Bleeding (HMB) is a significant cause of morbidity in premenopausal women in the UK. HMB is objectively defined as menstrual blood loss of more than 80ml/cycle, or menstrual bleeding lasting longer than 7 days, over several consecutive cycles. However the diagnosis is based on the women's subjective assessment of blood loss. Excessive menorrhagia affects one in five women in the productive age, is contribute to about 20% of all referrals for specialist gynaecology services. The amount of blood lost in each period varies with the individual. Because of this wide variation it is impossible to define a 'normal' period in terms of the amount, length and frequency of bleeding. Generally speaking, variations were noticed because of age, and in relation to periods before and after pregnancy. Menorrhagia is the term indicating heavy and regular periods. In about half the women with heavy periods, no cause can be found. However in others, menorrhagia could be due to: 1 Progestogen (levonorgestrel) Intrauterine system, I.U.S (Mirena) I.U.S is effective treatment for reducing heavy menstrual blood loss and should be considered an alternative to surgical treatment.
Lahteenmaki P etal (BMJ1998) reported from Finland that women who were fitted with a Levonorgestrel releasing intrauterine system while on the waiting list for a hysterectomy for menorrhagia, were so pleased with the results that 60% of them refused hysterectomy when their names came up for admission. Howevere, Mirena IUS not without problems such as water retention, weight gain, pain and irregular bleeding which some time forced women to demand removal after a short period of time.
MAS for Menorrhagia
Endometrial ablation techniques are now well established and the uptake of these alternative treatments of manorrhagia partly accounts for the fall in the number of hysterectomies performed in Europe over the past decade. Earlier techniques such as endometrial resection, rollerball coagulation and endometrial laser ablation (first generation methods), still regarded as gold standard in the MAS for menorrhagia.
Second generation techniques aim to induce permanent thermal damage. Both first and second generation techniques aimed to inflict permanent damage or resection of basal endometrium by heated fluid directly or indirectly onto the endometrium or by radiofrequency (rf) or laser energy resection or ablation.
First Generation MAS Endometrial resection by loop resection (resectoscopy) roller ball ablation of endometrium or laser ablation have been employed with the purpose of removing the entire thickness of the endometium (Peninsula Technology Group 2003) . The benefits acclaimed to those therapies to reduce trauma and post operative complications to the women, reduced the need for a general anaesthetic and shifting the procedure from inpatient to day case treatment. Indirectly, these procedures have saved considerable amounts of money to the society. However, these procedures need intensive training and capital for equipment, and the financial advantage has been reduced by the need to perform additional surgical treatment in case of recurrence of heavy periods. There was a significant advantage in favour of hysterectomy in improving heavy menstrual bleeding (HMB). Satisfaction rates (upto 4 years post surgery) compared with endometrial destruction techniques. Although the quality of life scales reported no difference between surgery groups, there was some evidence of a great improvement in general health for hysterectomy patients.
Duration of surgery, hospital stay and recovery were all shorter following endometrial destruction. Most adverse events, both major and minor, reported to be higher in the hysterectomy group compared to endometrial destruction.
Second generation MAS
for menorrhagia Thermal ablation: A number of hydrothermal ablation devices were introduced to gynaecological practice in North America and Europe since 1994. These devices have undergone several modifications with variable results and outcomes.
1.
Thermal balloon Ablation (Thermachoice)( Ethicon,Somerville,N.J.) 5mm catheter with fixed length silicon balloon at the end. After dilation of the cervix, the balloon inserted into the uterus and distended gradually with 5% dextrose until the pressure reaches 160-180mmHg. Once the desired temperature has been reached the procedure takes eight minutes. 2. Cavaterm plus (Walsten Medical,Morges Switzerland) Hand piece with a diameter of 6mm, has a silicon balloon of adjustable length at the distal end designed to fit uterine cavities of variable lengths. Once in the uterine cavity, the balloon is inflated with 5% dextrose and the pressure is maintained at 220-240mmHg. The desired temperature (65-78ºC) is maintained for 10minutes in order to achieve complete ablation. 
Outcome of balloon ablation
The presence of submucous fibroids or endometrial polyps may increase the failure rates for balloon-based devicesthis may be improved by using HTA. However, MAS for menorrhagia proved to be associated lower complication rates, short hospital stay, and short periods of recovery and cost effective compared to TAH. Compared with first generation techniques, HTA techniques are less operator dependant, therefore easy to handle and shorter learning curve in addition to much lower complication rates. Thermal injury to the bowels and urinary bladder can occur when the procedure is complicated by uterine perforation. The new devices have in built mechanisms to check for perforation before initiation of the procedure. Minor complications such as nausea and vomiting can occur in about 20-25% and postoperative cramping in up to 90%. Reported amenorrhoea rates vary from 30 to 60% and 53% with HTA and a success rate of up to 94%, with patient satisfaction up to 98%. Disposable devices cost between £250-400 per single use.
Other ablation devices using radiofrequency energy RF ( third generation) a. Novasure (Cytyc Surgical Products) Impedance controlled endometrial ablation system. The Novasure procedure is regarded to be one of the 21 st century's best endometrial thermal ablation, being the fastest ablation technique. The average time is 90 seconds. The hard piece attached to the thermal electrode array expands to conform to the contours of the uterine cavity. It has inbuilt cavity integrity assessment using a small amount of CO 2 . The electrode array delivers bipolar RF energy until complete ablation after 90 seconds, and then the electrode array is retracted for easy removal. The bipolar electrode design provides a shallower ablation (2-3mm) in the cornus and lower uterine segment and a deeper ablation (5-7mm) in the fundus and main body of the uterus. The system can alert the operator to a perforated uterine wall prior to treatment, this is an added safety feature to minimise intra and postoperative complications. 
